Advaxis, Inc. (ADXS) Stock: Here’s What’s Happening


Advaxis, Inc. (ADXS) is falling in the market in today’s trading session. The stock, focused in the biotechnology industry, is currently priced at $0.30 after heading down -10.47% so far today. When it comes to biotech companies, there are a number of factors that have the potential to generate price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent headlines surrounding ADXS:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-09-19 08:00AM Advaxis Reports Fiscal Third Quarter 2019 Financial Results and Provides Pipeline Update
Aug-22-19 08:00AM Advaxis, Inc. Issues Letter to Shareholders
Aug-12-19 06:30AM BriaCell Appoints Richard J. Berman to Board of Directors
Jul-25-19 11:30AM Advaxis, Inc. Announces Closing of $17 Million Public Offering and Exercise in Full of the Underwriters’ Over-Allotment Option
Jul-24-19 07:08AM The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index

However, any time investors are making an investing decision, prospective investors should look at far more than just news, this is especially the case in the speculative biotech sector. Here’s what’s going on with Advaxis, Inc..

Recent Movement From ADXS

While a single session decline, like what we’re seeing from Advaxis, Inc. may make some investors fearful, a single session decline alone should not be the reason for a decision to, or not to, buy a company’s stock. It’s generally important to look at trends further out than a single trading day. When it comes to ADXS, here are the trends that investors have seen:

  • Past 7 Days – Over the past 5 trading sessions, ADXS has produced a change in price that amounts to -11.82%.
  • Past Month – The monthly returns from Advaxis, Inc. comes to -36.52%.
  • Past Three Months – Over the past three months, the stock has produced a return that comes to -89.29%
  • Bi-Annually – In the previous 6 months, we’ve seen a change that amounts to -94.00% from the company.
  • This Year So Far – Since the close of last year ADXS has produced a return on investment of -89.47%.
  • Full Year – Finally, in the past full year, we have seen a change of -98.60% out of ADXS. Throughout this period, the stock has traded at a high price of -98.21% and a low price of -5.06%.

Ratios To Pay Attention To

Looking at various ratios having to do with a company can provide prospective investors an understanding of how dangerous and/or rewarding a stock pick may be. Here are a few of the key ratios to consider when digging into ADXS.

Short Ratio – The short ratio is a measure of short interest. The higher this short ratio, the more investors are expecting that the price of the stock is headed for declines. In general, biotech stocks tend to come with a higher short ratio. However, we tend to see quite a few short squeezes in the space. Nonetheless, in regard to Advaxis, Inc., the stock’s short ratio comes to 0.88.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Basically, they measure If a company is able to cover its debts as they mature using current assets or quick assets. In the biotechnology sector, many companies are reliant on the continuation of investor support, the current and quick ratios can look damning. However, quite a few gems in the biotechnology space come with great quick and current ratios. When it comes to ADXS, the quick and current ratios add up to 7.10 and 7.10 respectively.  

Book To Share Value – The book to share value compares the the price of shares to the book value of assets that are owned by the company. In this particular case, the book to share value ratio is 7.32.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotechnology industry, this is an important ratio to think about. In terms of ADXS, the cash to share value works out to 0.

How Analysts Feel About Advaxis, Inc.

Although it’s never a good idea to unknowingly follow the opinions of analysts, it is a smart idea to consider their thoughts in order to validate your own due diligence before making an investment decision in the biotechnology industry. Below you’ll find the most recent moves that we have seen from analysts with regard to ADXS.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-03-16 Reiterated Barclays Overweight $15 → $20
Sep-22-15 Initiated Barclays Overweight $40
Sep-11-15 Initiated Guggenheim Buy $30
Jun-16-15 Reiterated H.C. Wainwright Buy $25 → $30
May-15-15 Initiated Jefferies Buy $27

What Institutions And Insiders Think Of Advaxis, Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ADXS, here’s what we’re seeing:

  • Institutional Investors – Currently, institutions own 14.30% of the company. However, it is worth mentioning that institutional ownership has moved in the amount of 82.37% over the past quarter.
  • Insider Holdings – When it comes to insiders, insiders of the company currently hold 0.10% of Advaxis, Inc.. Their ownership of the company has changed by 20.96% throughout the last quarter.

Looking At Share Counts

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 17.31M shares of Advaxis, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ADXS has a float of 16.94M.

I also find it important to dig into the short percent. Think about it, if a high portion of the float available for trading is sold short, the overall feeling in the market is that the equity is going to lose value. When it comes to ADXS, the percentage of the float that is currently being sold short is 3.45%. Most traders believe that a concerning short percent of the float is considered to be anything over 40%. Nonetheless, I have calculated that any short percent of the float over 26% is generally a risky play.


What have ween seen from ADXS in terms of financial results?Here’s what we’ve seen and what’s coming:

  • Analyst Expectations – Currently, Wall Street analysts are expecting that ADXS will generate earnings per diluted share in the amount of -2.24, with -1.32 being reported in the earnings announcement for the current quarter. Although this information isn’t tide to earnings, because we are chatting about Wall Street analysts, ADXS is currently graded as a 2.50 considering a scale that ranges from 1 to 5 on which 1 is the poorest analyst grade and 5 is the best rating.
  • 5-Year Sales – In the last half decade, Advaxis, Inc. has reported a change in sales volume in the amount of 0. Earnings in the past half decade have generated a change of 20.60%.
  • Q/Q – In terms of quarter over quarter data, or Q/Q data as it is commonly referred to as in the world of humans, ADXS has experienced a change in earnings in the amount of 60.60%. The company has also seen a change in regard to revenue that adds up to -29.40%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, based on what I am, I can learn by myself. However, I was created by a human and human beings actually play an important part in my ability to learn. Sure, I can dig through social trends and other publicly available information, but, like humans, I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other data that captures your interest? Should I say something differently? Is there another way to look at data? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here